Standards for collecting and preparing samples for diagnosis or medical research
The former SPIDIA consortium (2008–2013) was a 4.5-years project funded by the European Union FP7 programme, and it involved 16 partners (7 private research companies, 8 public research organisations, and 1 European Standards Organisation) from 11 different European countries, all key experts in pre-analytical procedures.
The SPIDIA4P project, funded by the European Union’s Horizon 2020 research and innovation programme, started on January 1st 2017, and it builds on SPIDIA’s results. The consortium is coordinated by QIAGEN GmbH (Germany), a diagnostic and life science company, and is composed of 19 highly experienced partners in international standardisation for in vitro diagnostics, coming from private industry including SMEs, public institutions and from one official European Standards Organisation (CEN).
SPIDIA4P partners are European world-class leaders in their fields of activity, publishing in the best journals and inventing key products for the medical and scientific community, and they are key experts in European and international standardisation organisations’ processes (CEN and ISO), external quality assurance, quality management, ethics and regulatory demands.
Find out more about SPIDIA and SPIDIA4P: background, ethics, objectives, strategies and more.
SPIDIA4P focuses on the development and implementation of standards for collecting and preparing body materials taken for diagnosis or medical research. Standards reduce variations in the samples, leading to more reliable and reproducible results.